Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape
dc.contributor.author | Parihar, Suraj P | en_ZA |
dc.contributor.author | Guler, Reto | en_ZA |
dc.contributor.author | Lang, Dirk M | en_ZA |
dc.contributor.author | Suzuki, Harukazu | en_ZA |
dc.contributor.author | Marais, A David | en_ZA |
dc.contributor.author | Brombacher, Frank | en_ZA |
dc.date.accessioned | 2016-01-11T06:53:23Z | |
dc.date.available | 2016-01-11T06:53:23Z | |
dc.date.issued | 2013 | en_ZA |
dc.description.abstract | Statins are well-known cholesterol lowering drugs targeting HMG-CoA-reductase, reducing the risk of coronary disorders and hypercholesterolemia. Statins are also involved in immunomodulation, which might influence the outcome of bacterial infection. Hence, a possible effect of statin treatment on Listeriosis was explored in mice. Statin treatment prior to subsequent L. monocytogenes infection strikingly reduced bacterial burden in liver and spleen (up to 100-fold) and reduced histopathological lesions. Statin-treatment in infected macrophages resulted in increased IL-12p40 and TNF-α and up to 4-fold reduced bacterial burden within 6 hours post infection, demonstrating a direct effect of statins on limiting bacterial growth in macrophages. Bacterial uptake was normal investigated in microbeads and GFP-expressing Listeria experiments by confocal microscopy. However, intracellular membrane-bound cholesterol level was decreased, as analyzed by cholesterol-dependent filipin staining and cellular lipid extraction. Mevalonate supplementation restored statin-inhibited cholesterol biosynthesis and reverted bacterial growth in Listeria monocytogenes but not in listeriolysin O (LLO)-deficient Listeria . Together, these results suggest that statin pretreatment increases protection against L. monocytogenes infection by reducing membrane cholesterol in macrophages and thereby preventing effectivity of the cholesterol-dependent LLO-mediated phagosomal escape of bacteria. | en_ZA |
dc.identifier.apacitation | Parihar, S. P., Guler, R., Lang, D. M., Suzuki, H., Marais, A. D., & Brombacher, F. (2013). Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape. <i>PLoS One</i>, http://hdl.handle.net/11427/16272 | en_ZA |
dc.identifier.chicagocitation | Parihar, Suraj P, Reto Guler, Dirk M Lang, Harukazu Suzuki, A David Marais, and Frank Brombacher "Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape." <i>PLoS One</i> (2013) http://hdl.handle.net/11427/16272 | en_ZA |
dc.identifier.citation | Parihar, S. P., Guler, R., Lang, D. M., Suzuki, H., Marais, A. D., & Brombacher, F. (2013). Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape. PloS one, 8(9), e75490. doi:10.1371/journal.pone.0075490 | en_ZA |
dc.identifier.ris | TY - Journal Article AU - Parihar, Suraj P AU - Guler, Reto AU - Lang, Dirk M AU - Suzuki, Harukazu AU - Marais, A David AU - Brombacher, Frank AB - Statins are well-known cholesterol lowering drugs targeting HMG-CoA-reductase, reducing the risk of coronary disorders and hypercholesterolemia. Statins are also involved in immunomodulation, which might influence the outcome of bacterial infection. Hence, a possible effect of statin treatment on Listeriosis was explored in mice. Statin treatment prior to subsequent L. monocytogenes infection strikingly reduced bacterial burden in liver and spleen (up to 100-fold) and reduced histopathological lesions. Statin-treatment in infected macrophages resulted in increased IL-12p40 and TNF-α and up to 4-fold reduced bacterial burden within 6 hours post infection, demonstrating a direct effect of statins on limiting bacterial growth in macrophages. Bacterial uptake was normal investigated in microbeads and GFP-expressing Listeria experiments by confocal microscopy. However, intracellular membrane-bound cholesterol level was decreased, as analyzed by cholesterol-dependent filipin staining and cellular lipid extraction. Mevalonate supplementation restored statin-inhibited cholesterol biosynthesis and reverted bacterial growth in Listeria monocytogenes but not in listeriolysin O (LLO)-deficient Listeria . Together, these results suggest that statin pretreatment increases protection against L. monocytogenes infection by reducing membrane cholesterol in macrophages and thereby preventing effectivity of the cholesterol-dependent LLO-mediated phagosomal escape of bacteria. DA - 2013 DB - OpenUCT DO - 10.1371/journal.pone.0075490 DP - University of Cape Town J1 - PLoS One LK - https://open.uct.ac.za PB - University of Cape Town PY - 2013 T1 - Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape TI - Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape UR - http://hdl.handle.net/11427/16272 ER - | en_ZA |
dc.identifier.uri | http://hdl.handle.net/11427/16272 | |
dc.identifier.uri | http://dx.doi.org/10.1371/journal.pone.0075490 | |
dc.identifier.vancouvercitation | Parihar SP, Guler R, Lang DM, Suzuki H, Marais AD, Brombacher F. Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape. PLoS One. 2013; http://hdl.handle.net/11427/16272. | en_ZA |
dc.language.iso | eng | en_ZA |
dc.publisher | Public Library of Science | en_ZA |
dc.publisher.department | Institute of Infectious Disease and Molecular Medicine | en_ZA |
dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
dc.publisher.institution | University of Cape Town | |
dc.rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en_ZA |
dc.rights.holder | © 2013 Parihar et al | en_ZA |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | en_ZA |
dc.source | PLoS One | en_ZA |
dc.source.uri | http://journals.plos.org/plosone | en_ZA |
dc.subject.other | Macrophages | en_ZA |
dc.subject.other | Listeria monocytogenes | en_ZA |
dc.subject.other | Statins | en_ZA |
dc.subject.other | Cholesterol | en_ZA |
dc.subject.other | Listeria | en_ZA |
dc.subject.other | Bacterial growth | en_ZA |
dc.subject.other | Mouse models | en_ZA |
dc.subject.other | Intracellular membranes | en_ZA |
dc.title | Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape | en_ZA |
dc.type | Journal Article | en_ZA |
uct.type.filetype | Text | |
uct.type.filetype | Image | |
uct.type.publication | Research | en_ZA |
uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Parihar_Simvastatin_Enhances_Protection_2013.pdf
- Size:
- 1.58 MB
- Format:
- Adobe Portable Document Format
- Description: